Cisplatin and Doxorubicin Induce Distinct Mechanisms of Ovarian Follicle Loss; Imatinib Provides Selective Protection Only Against Cisplatin

PLoS ONE - United States
doi 10.1371/journal.pone.0070117
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Cisplatin-Induced Primordial Follicle Oocyte Killing and Loss of Fertility Are Not Prevented by Imatinib

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

Cisplatin Versus Cisplatin Plus Doxorubicin for Standard-Risk Hepatoblastoma

New England Journal of Medicine
Medicine
2009English

Randomized Comparison of Doxorubicin Alone Versus Ifosfamide Plus Doxorubicin or Mitomycin, Doxorubicin, and Cisplatin Against Advanced Soft Tissue Sarcomas.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
1993English

Magnesium Protects Against Cisplatin-Induced Acute Kidney Injury Without Compromising Cisplatin-Mediated Killing of an Ovarian Tumor Xenograft in Mice

American Journal of Physiology - Renal Physiology
UrologyPhysiology
2015English

Reversibility of Cisplatin-Induced Hearing Loss

AUDIOLOGY JAPAN
2003English

Mitigating Cisplatin Resistance in Ovarian Cancer.

English

Proteomic Analysis of Cisplatin-Resistant Ovarian Concers

2006English

Cisplatin/Carboplatin Cross-Resistance in Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

Resensitization of Cisplatin Resistance Ovarian Cancer Cells to Cisplatin Through Pretreatment With Low‐dose Fraction Radiation

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy